A Study of MabThera (Rituximab) in Patients With Rheumatoid Arthritis Who Have Had an Inadequate Response to a Single Anti-TNF Inhibitor.
This study is ongoing, but not recruiting participants.
Information provided by (Responsible Party):
First received: December 18, 2007
Last updated: October 10, 2012
Last verified: October 2012
No Study Results Posted on ClinicalTrials.gov for this Study
|Study Status:||This study is ongoing, but not recruiting participants.|
|Estimated Study Completion Date:||December 2012|
|Estimated Primary Completion Date:||No date given|